We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Open label extension study demonstrates safety and efficacy of tamoxifen in Duchenne muscular dystrophy, suggesting potential therapeutic benefits.
No takes yet. Share an insight, caveat, or question.
Zwingli et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: